Back to Search Start Over

Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria?

Authors :
Celine Loncle
Chanaz Salmi
Jean-Marie Pagès
Yves Letourneux
Nicolas Vidal
Marc Maresca
Nadira Taïeb
Jean Michel Brunel
Jacques Fantini
Transporteurs membranaires, chimioresistance et drug-design (TMCD2)
Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Centre de recherche en neurobiologie - neurophysiologie de Marseille (CRN2M)
Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE)
Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48
Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)
Dumonceaud, Corinne
INSB-INSB-Centre National de la Recherche Scientifique (CNRS)
Source :
PLoS ONE, PLoS ONE, 2008, 3 (7), pp.e2765. ⟨10.1371/journal.pone.0002765⟩, Plos One 7 (3), 8 p.. (2008), PLoS ONE, Public Library of Science, 2008, 3 (7), pp.e2765. ⟨10.1371/journal.pone.0002765⟩, PLoS ONE, Vol 3, Iss 7, p e2765 (2008)
Publication Year :
2008
Publisher :
HAL CCSD, 2008.

Abstract

International audience; We reported that squalamine is a membrane-active molecule that targets the membrane integrity as demonstrated by the ATP release and dye entry. In this context, its activity may depend on the membrane lipid composition. This molecule shows a preserved activity against bacterial pathogens presenting a noticeable multi-resistance phenotype against antibiotics such as polymyxin B. In this context and because of its structure, action and its relative insensitivity to efflux resistance mechanisms, we have demonstrated that squalamine appears as an alternate way to combat MDR pathogens and by pass the gap regarding the failure of new active antibacterial molecules.

Details

Language :
English
ISSN :
19326203
Database :
OpenAIRE
Journal :
PLoS ONE, PLoS ONE, 2008, 3 (7), pp.e2765. ⟨10.1371/journal.pone.0002765⟩, Plos One 7 (3), 8 p.. (2008), PLoS ONE, Public Library of Science, 2008, 3 (7), pp.e2765. ⟨10.1371/journal.pone.0002765⟩, PLoS ONE, Vol 3, Iss 7, p e2765 (2008)
Accession number :
edsair.doi.dedup.....20d0b54061950136c3f6f25d398b647a
Full Text :
https://doi.org/10.1371/journal.pone.0002765⟩